Towards the next step: LoViRet patients for HIV-1 cure studies

EBioMedicine. 2020 Aug:58:102889. doi: 10.1016/j.ebiom.2020.102889. Epub 2020 Jul 20.

Authors

Raquel Crespo¹, Casper Rokx², Tokameh Mahmoudi³

Affiliations

¹ Department of Biochemistry, Erasmus University Medical Center, Ee622 PO Box 2040, 3000CA Rotterdam, the Netherlands.
² Department of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Center, Rg-530, PO BOC 2040, 3000CA Rotterdam, the Netherlands.
³ Department of Biochemistry, Erasmus University Medical Center, Ee622 PO Box 2040, 3000CA Rotterdam, the Netherlands. Electronic address: t.mahmoudi@erasmusmc.nl.

No abstract available

Publication types

Comment

MeSH terms

Anti-HIV Agents* / therapeutic use
HIV Seropositivity* / drug therapy
HIV-1*
Humans

Substances

Anti-HIV Agents